Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Jim Cramer Calls Affirm 'A Winner,' But Not C3.ai: 'I Can't Recommend A Stock With No Earnings'

Published 13/02/2024, 14:55
© Reuters.  Jim Cramer Calls Affirm 'A Winner,' But Not C3.ai: 'I Can't Recommend A Stock With No Earnings'

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Vertiv Holdings Co (NYSE: VRT) is "one of the great performers of our time."

Vertiv is expected to report its fourth quarter results before the opening bell on Feb. 21, 2024. Analysts expect the company to report quarterly earnings at 53 cents per share, up from 28 cents per share in the year-ago period. The company is projected to report revenue of $1.88 billion, compared to $1.65 billion in the year-earlier quarter.

Cramer recommended sticking with General Dynamics Corporation (NYSE: GD). "I like that CEO, it’s just terrific," he added.

General Dynamic recently reported better-than-expected fourth-quarter sales results, posting revenue growth of 7.5% year-over-year to $11.67 billion, beating the consensus of $11.37 billion.

"That’s Tom Siebel [CEO of C3.ai], I happen to like Tom. I don’t see any earnings there," Cramer said when asked about C3.ai, Inc. (NYSE: AI). "I can’t recommend a stock that has no earnings."

C3.ai announced that it will host its annual AI conference, C3 Transform 2024, from March 5 to March 7 and will focus on how generative AI is delivering productivity and efficiency benefits across industries.

Don’t forget to check out our premarket coverage here

Altimmune, Inc. (NASDAQ: ALT) is a "good spec, but that’s what it is, it’s spec," the "Mad Money" host said.

Goldman Sachs analyst Corinne Jenkins, last month, reinstated Altimmune with a Neutral and announced a $13 price target.

Cramer recommended buying Affirm Holdings, Inc. (NASDAQ: AFRM). "You’ve got a winner with Affirm," he added.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Affirm said fiscal second-quarter revenue increased 48% year-over-year to $591.1 million, which beat the consensus estimate of $520.62 million, according to Benzinga Pro. The company reported a loss of 54 cents per share, which beat analyst estimates for a loss of 72 cents per share.

Darling Ingredients Inc. (NYSE: DAR) is a "really interesting" company, but the stock keeps going lower. "It’s too inexpensive to go, I’m going to leave it like that," he added.

Citigroup analyst Thomas Palmer recently initiated coverage on Darling Ingredients with a Neutral rating and announced a price target of $49.

Price Action:

  • Shares of Vertiv Holdings fell 3.5% to close at $61.32 on Monday.
  • General Dynamics shares fell 0.3% to $269.44 on Monday.
  • C3.ai shares rose 9.5% to settle at $31.18 during Monday’s session.
  • Shares of Altimmune fell 0.4% to close at $10.40 on Monday.
  • Affirm shares rose 2.6% to settle at $45.00 on Monday.
  • Shares of Darling Ingredients gained 3.7% to close at $43.10 during the session.

Image: Shutterstock

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.